Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
AstraZeneca
McKesson
Harvard Business School
Colorcon
Merck

Last Updated: December 5, 2022

Clopidogrel bisulfate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic drug sources for clopidogrel bisulfate and what is the scope of patent protection?

Clopidogrel bisulfate is the generic ingredient in two branded drugs marketed by Accord Hlthcare, Acme Labs, Actavis Totowa, Amneal Pharms, Ani Pharms, Apotex Inc, Aurobindo Pharma Ltd, Cadila, Celltrion, Dr Reddys, Dr Reddys Labs Ltd, Graviti Pharms, Macleods Pharms Ltd, Polygen Pharms, Prinston Inc, Rising, Sciegen Pharms Inc, Sun Pharm, Sun Pharm Industries, Teva, Torrent Pharms Ltd, and Sanofi Aventis Us, and is included in twenty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are forty-five drug master file entries for clopidogrel bisulfate. Thirty-nine suppliers are listed for this compound.

Drug Prices for clopidogrel bisulfate

See drug prices for clopidogrel bisulfate

Drug Sales Revenue Trends for clopidogrel bisulfate

See drug sales revenues for clopidogrel bisulfate

Recent Clinical Trials for clopidogrel bisulfate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Joint Stock Company "Farmak"Phase 1
Xinhua Hospital, Shanghai Jiao Tong University School of MedicineN/A
The First Affiliated Hospital with Nanjing Medical UniversityPhase 4

See all clopidogrel bisulfate clinical trials

Pharmacology for clopidogrel bisulfate
Paragraph IV (Patent) Challenges for CLOPIDOGREL BISULFATE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
PLAVIX Tablets clopidogrel bisulfate 300 mg 020839 1 2009-03-04

US Patents and Regulatory Information for clopidogrel bisulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd CLOPIDOGREL BISULFATE clopidogrel bisulfate TABLET;ORAL 090540-001 May 17, 2012 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Rising CLOPIDOGREL BISULFATE clopidogrel bisulfate TABLET;ORAL 077665-002 May 17, 2012 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Cadila CLOPIDOGREL BISULFATE clopidogrel bisulfate TABLET;ORAL 201686-001 Oct 10, 2012 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Torrent Pharms Ltd CLOPIDOGREL BISULFATE clopidogrel bisulfate TABLET;ORAL 090844-001 May 17, 2012 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for clopidogrel bisulfate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us PLAVIX clopidogrel bisulfate TABLET;ORAL 020839-001 Nov 17, 1997 See Plans and Pricing See Plans and Pricing
Sanofi Aventis Us PLAVIX clopidogrel bisulfate TABLET;ORAL 020839-001 Nov 17, 1997 See Plans and Pricing See Plans and Pricing
Sanofi Aventis Us PLAVIX clopidogrel bisulfate TABLET;ORAL 020839-002 Sep 20, 2007 See Plans and Pricing See Plans and Pricing
Sanofi Aventis Us PLAVIX clopidogrel bisulfate TABLET;ORAL 020839-001 Nov 17, 1997 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Boehringer Ingelheim
McKinsey
Medtronic
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.